NFKB1 and neoplasm: The inappropriate regulation of the signaling pathway, as well as the altered expression of various proinflammatory transcription factors, mainly NF-κB, STAT families, and activating protein-1 (AP-1), have been reported as stimulators in tumor development and progression [12,13,14].